Off-label means that a drug:
A. is available in Europe but not in the United States.
B. is FDA approved for one use but being prescribed for another purpose.
C. is in the fast-track process for FDA approval.
D. has no FDA approval in any country.
Question 2
The nurse is teaching a patient about the loss of potassium when taking diuretics. The physician started this patient on spironolactone (Aldactone). What is special about this diuretic?
1. It blocks active transport of sodium and potassium excretion.
2. It is used when there is high renal filtration.
3. It affects the exchange of sodium and potassium excretion.
4. It gives a peak effect in diuretic use.